ritlecitinib exhibits high selectivity towards Janus kinase 3 (JAK3) and tyrosine kinases in the TEC family.
It blocks the immune intracellular signaling pathway that causes alopecia areata by inhibiting JAK3 dependent receptor-mediated cytokine induced STAT phosphorylation and TEC kinase family member dependent immune receptor signaling.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: